172 related articles for article (PubMed ID: 10776806)
1. H2-blocker modulates heart rate variability.
Ooie T; Saikawa T; Hara M; Ono H; Seike M; Sakata T
Heart Vessels; 1999; 14(3):137-42. PubMed ID: 10776806
[TBL] [Abstract][Full Text] [Related]
2. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
[TBL] [Abstract][Full Text] [Related]
3. Lichenoid eruptions due to the H2-receptor antagonists roxatidine and ranitidine.
Horiuchi Y; Katagiri T
J Dermatol; 1996 Jul; 23(7):510-2. PubMed ID: 8772037
[No Abstract] [Full Text] [Related]
4. Omeprazole, H2 blockers, and polyarthralgia: case-control study.
Meier CR; Jick H
BMJ; 1997 Nov; 315(7118):1283. PubMed ID: 9390057
[No Abstract] [Full Text] [Related]
5. Effects of the selective H1 and H2 histamine receptor antagonists loratadine and ranitidine on autonomic control of the heart.
Nault MA; Milne B; Parlow JL
Anesthesiology; 2002 Feb; 96(2):336-41. PubMed ID: 11818765
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
7. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
10. Case report: ranitidine-induced bradycardia in a patient with dextrocardia.
Yang J; Russell DA; Bourdeau JE
Am J Med Sci; 1996 Sep; 312(3):133-5. PubMed ID: 8783681
[TBL] [Abstract][Full Text] [Related]
11. Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
Arroyo MT; Lanas A; Sáinz R
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):313-8. PubMed ID: 10750652
[TBL] [Abstract][Full Text] [Related]
12. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration].
Takimoto R; Mogi Y; Kura T; Niitsu Y
Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group.
Brandstätter G; Marks IN; Lanza F; Kogut D; Cobert B; Savitsky JP; Bender W; Labs R; Wurzer H
Clin Ther; 1995; 17(3):467-78. PubMed ID: 7585851
[TBL] [Abstract][Full Text] [Related]
15. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding.
Riemann JF; Schilling D; Schauwecker P; Wehlen G; Dorlars D; Kohler B; Maier M
Gastrointest Endosc; 1997 Oct; 46(4):299-304. PubMed ID: 9351030
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of acid and gastric carcinoids.
Elder JB
Gut; 1985 Dec; 26(12):1279-83. PubMed ID: 2867953
[No Abstract] [Full Text] [Related]
17. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
[TBL] [Abstract][Full Text] [Related]
20. [Symptomatic high chromogranin A level associated with rabeprazole and ranitidine].
Fraisse T; Pochic J; Pinzani V; Balducchi JP; Arnaud E; de Wazières B
Therapie; 2006; 61(1):79-80. PubMed ID: 16792160
[No Abstract] [Full Text] [Related]
[Next] [New Search]